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Abstract
Background Our study analyzes the incidence of sleep problems and their mediating role on depression and anxious preoc-
cupation in patients with resected, non-advanced cancer.
Methods A multi-institutional, prospective, observational study was conducted with 750 participants of 14 hospitals in 
Spain. Participants’ socio-demographic and clinical characteristics were collected using a standardized self-report form and 
using EORTC QoL-QLQ-C30, BSI, Mini-MAC questionnaires.
Results In women, sleep problems, depression and anxious preoccupation were observed in 65, 41 and 21%, respectively. In 
men, sleep problems, depression and anxious preoccupation were reported in 51, 29 and 61%, respectively. More sleep prob-
lems, depression and anxious preoccupation were found among women than males. Depression was a significant predictor 
of anxious preoccupation. In males, sleep problems partially mediated this association. This was not confirmed in women.
Conclusion Our findings point toward the importance of developing interventions that decrease depression and sleep prob-
lems in cancer.
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Introduction
Adjuvant chemotherapy following cancer resection increases 
survival in patients at risk for recurrence. High levels of anx-
ious preoccupation often emerge during the pre-treatment 
period due to fear surrounding treatment side effects and 
recurrence [1]. Likewise, anxious preoccupation has been 
associated with depression and insomnia [2]. Similarly, 
depression is also common in oncological patients and can 
aggravate sleep disturbances [3] and together can contribute 
to anxious preoccupation, a coping strategy deemed inap-
propriate [4].
Sleep problems are prevalent in cancer patients [5], nearly 
two-thirds of patients reported symptoms including long 
latency periods before falling or staying asleep, frequent 
nocturnal awakenings, and impaired seep quality [6]. Higher 
levels of sleep problems predicted for more fatigue, depres-
sion and poorer performance status [7].
Few studies have examined anxious preoccupation in 
individuals about to receive chemotherapy, yet, in our series, 
it was present in 15.8% [1].
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Our objective was to analyze the prevalence of depres-
sion, anxious preoccupation and sleep disorders in a pop-
ulation of patients with a resected non-advanced cancer 
grouped by gender and to know the mediational role of sleep 




A multi-institutional, prospective, observational study was 
conducted with the participation of 14 hospitals in Spain 
from June 2015 to June 2018. NEOcoping is a cancer patient 
research program funded by the Continuous Care Group of 
the Spanish Society of Medical Oncology (SEOM). The 
study was approved by the Ethics Committee of each insti-
tution and by the Spanish Agency of Medicines and Medi-
cal Devices (AEMPS). Participants were 18 years of age or 
older with resected, non-advanced, histologically confirmed, 
solid cancer and eligible for adjuvant chemotherapy.
Measures
Participants’ socio-demographic characteristics were col-
lected using a standardized self-report form. Information 
related to participants’ disease was obtained by reviewing 
their medical history.
Sleep problems: participant’s subjective sleep was meas-
ured using the corresponding scale of a multidimensional 
questionnaire of health related quality of life (HRQoL), the 
EORTC QoL Questionnaire C30 (QLQ-C30) version 2.0 
[8]. The questionnaire involves one straightforward question: 
‘during the past week, have you had trouble sleeping?’ It 
was considered that patients had subjective sleep problems 
if they answered, ‘a little’, ‘quite a bit’ and ‘very much’, cor-
responding to 33.3, 66.7 or 100 values on the scale, respec-
tively. This cut-off point was similar to that used by other 
authors [5]. In this study, Cronbach’s alpha for the scale 
was 0.88.
Depression was measured using the Brief Symptom 
Inventory (BSI) 6-item depression subscale [9], designed to 
assess symptoms of disaffection and dysphoric mood, e.g., 
those reflecting self-deprecation, anhedonia, hopelessness, 
and suicidal ideation. Raw scores were converted to T scores 
[9]. In the present study, internal consistency was 0.75.
Anxious preoccupation
The anxious preoccupation subscale of the Mini-Mental 
Adjustment to Cancer (Mini-MAC) scale was administered 
to quantify dysfunctional coping in response to cancer. It 
was taken from the Spanish version of the Mini-MAC [4] 
and consists of eight items (e.g., “I worry about the cancer 
returning or getting worse”), each measuring the tendency 
toward constant preoccupation with cancer as an event caus-
ing feelings of devastation, anxiety, fear, and apprehension. 
Responses above the 85th percentile (one standard deviation 
(SD) above the mean) were interpreted as clinically signifi-
cant for high levels of anxious preoccupation. In this study, 
Cronbach’s alpha for the scale range from 0.55 to 0.80 [10].
Statistical analyses
Chi-square and t test were conducted to compare partici-
pants and no-participants’ socio-demographic and clinic 
characteristics. Mediation analyses were performed to deter-
mine whether perceived stress mediated in the association 
of depression and anxious preoccupation-based coping in 
patients. Separate models were run for anxious preoccupa-
tion and path coefficients, and bootstrapped confidence inter-
vals were estimated. Analyses were run on the IBM-SPSS 
23.0 statistical software package for Windows PC.
Results
Of the 835 patients recruited, 750 were eligible and the other 
85 did not meet the inclusion criteria or met at least some 
exclusion criteria. No significant intergroup differences were 
detected regarding socio-demographic and clinical baseline 
characteristics; see Table 1.
Sleep problems were observed in 65.5% of women and 
51.1% of men. Reported sleep problems in women (median 
(M) = 36.4, SD= 33.9) was significantly higher than in 
men (M= 25.1, SD = 29.6), t(748) = 4.794, p < 0.001, 
d = 0.35–41.1% of women and 28.6% of men reported 
depression problems. There was significantly more per-
ceived depression among women (M= 61.5, SD= 6.0) 
than men (M= 59.3, SD= 5.6, t(748) = − 5.257), p < 0.001, 
d = 0.37. Clinically significant scores in anxious preoccupa-
tion were displayed by 21.2% of women and 15.8% of men. 
More anxious preoccupation was also found among females 
(M= 43.1, SD= 25.6) versus males (M= 38.7, SD= 24.4, 
t(748) = − 3.160), p < 0.002, d = 0.23.
Mediation analyses
Depression was a significant predictor of anxious preoc-
cupation (Fig. 1a). Among males, sleep problems partially 
mediated this association, confirmed by the significant, 
indirect effect of depression on sleep problems (indirect 
effect = 0.06: 95% confidence interval = 0.02–0.12, Sobel 
z = − 3.023, p < 0.002). This was not confirmed in women 
(Sobel z = 1.129, p = 0.258) (Fig. 1b).
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Discussion
This study examines sleep problems in cancer patients who 
will initiate adjuvant chemotherapy and confirms its high 
prevalence in both women and men, 65.5% and 51.1%, 
respectively. Sleep problems (experienced between 12.5% 
and 56%) is one of the most prevalent symptom in cancer 
patients and survivors [5, 7, 11]. The possible causes of 
this wide range of prevalence may be due to demographic 
variables such as age, type of tumor, and type of treatment 
[6, 11]. Sleep problems together with depression predicted 
poor QoL in colorectal patients, the largest group in this 
series [7].
In the present study, women presented more sleep prob-
lems, depression and anxious preoccupation than men. 
Similar to that found in other studies [12]. Breast cancer 
patients with a sleep problem were more likely to experi-
enced complications and had longer hospital stays [13], and 
worse QoL [14].
This study also evaluates a mediation model that hypoth-
esizes that sleep problems mediate the association between 
Table 1  Socio-demographic 
and clinical characteristics 
of participants and non-
participants
Characteristics Participants (n = 750) No-participants 
(n = 85)
p value
Age (mean; SD) 59.7 (12.2) 58.4 (11.1) 0.444
Gender (n, % female) 434 (57.9) 68 (75.0) 0.233
Marital status (n, % married or partnered) 570 (76.0) 68 (75.0) 0.936
Education (years, n, SD) 7.9 (4.8) 7.8 (4.8) 0.667
Employment status (n, % inactive) 450 (60.0) 61 (67.0) 0.640
Tumor localization (n, SD) 0.105
 Colon 329 (43.9) 26 (28.5)
 Breast 235 (31.3) 45 (49.4)
 Others 186 (24.8) 20 (21.9)
Tumor stage (n, % I–II) 401 (55.2) 53 (58.2) 0.738
Chemo- and radiotherapy (n, %) 245 (32.7) 37 (40.7) 0.105
Fig. 1  Test of sleep problems as mediator of association between 
depression and anxious preoccupation. Mediation model showing 
that the effect of depression (independent variable) on anxious pre-
occupation (outcome) is mediated by sleep problems (mediator). 
Changes in Beta weights when the mediator is present are showed 
in c’. The result in the first step indicated that depression (B = − 0.53 
and B = 0.60) predicted anxious preoccupation. When sleep problems 
(mediator) were controlled the weight of depression was reduced 
over anxious preoccupation but it was still significant (B = 0.47 and 
B = 0.58). Sleep problems, as a mediator, predicted anxious pre-
occupation even when depression was controlled (B = − 0.15 and 
B = − 0.05). Sleep problems improved the prediction of anxious pre-
occupation over-and-above the independent variable (depression). a, 
direct effect of independent variable (IV) on mediator (M); b, direct 
effect of M on dependent variable (DV); c, direct effect of IV on DV; 
c’, indirect effect of IV on DV; B, beta weights. *p < 0.05, **p < 0.01, 
***p < 0.001
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anxious preoccupation and depression. The model was 
confirmed in men, albeit not in women, indicating that the 
greater the depression, the more sleep problems leading to 
increased anxious preoccupation in men. This demonstrates 
the association between depression and negative conse-
quences for physical and psychological health [15]. Among 
females, the non-confirmation of the mediation model would 
indicate that there are other variables that account for anx-
ious preoccupation and should be contemplated in future 
studies, including fear of deterioration of body image, per-
sonality, perceived social and family support.
The strengths of this study include its prospective, mul-
ticenter design, and a large sample of patients with non-
advanced resected cancer. Its limitations include the mod-
est effect size, use of self-reports that can lead to response 
biases such as social desirability, memory errors, etc., and 
the cross-sectional design that prevents directionality from 
being inferred.
Our findings point toward the importance of developing 
interventions that decrease depression and sleep problems 
in men with cancer. This may help them in their coping 
strategies with evidence-based approaches, such as cogni-
tive and/or behavioral treatments that incorporate relaxa-
tion techniques. Future studies should investigate how these 
states evolve over time and incorporate objective measures 
of sleep quality.
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